104
Participants
Start Date
July 15, 2019
Primary Completion Date
March 30, 2022
Study Completion Date
June 30, 2023
buprenorphine/naloxone
"A mobile team will be led by a nurse practitioner (able to prescribe buprenorphine/naloxone in PA) and include a peer recovery specialist (PRS), and a case manager. The team will rapidly confirm opioid use disorder and risk of overdose, complete informed consent, and begin induction procedures for a transitional (one month) course of buprenorphine/naloxone treatment. During this time, the dedicated case manager and PRS will work with the participants to help them become engaged in existing medication assisted treatment programs"
University of Pennsylvania, Philadelphia
Prevention Point Philadelphia
OTHER
Public Health Management Corporation
OTHER
Philadelphia Department of Public Health
OTHER_GOV
University of Pennsylvania
OTHER